Gene · 5481
Papers1,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Could "cellular exercise" be the missing ingredient in a healthy life? Diets, caloric restriction, and exercise-induced hormesis. | Nutrition | 2022 | 35489165 | PubTator, text mining | PubMed |
| Study on the mechanism of Wuzi-Yanzong-Wan-medicated serum interfering with the mitochondrial permeability transition pore in the GC-2 cell induced by atractyloside. | Chin J Nat Med | 2022 | 35487598 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Platelets in Viral Infections - Brave Soldiers or Trojan Horses. | Front Immunol | 2022 | 35419008 | PubTator, text mining | PubMed |
| Unbiased proteomics, histochemistry, and mitochondrial DNA copy number reveal better mitochondrial health in muscle of high-functioning octogenarians. | Elife | 2022 | 35404238 | PubTator, text mining | PubMed |
| Sirtuin 3 and mitochondrial permeability transition pore (mPTP): A systematic review. | Mitochondrion | 2022 | 35346868 | PubTator, text mining | PubMed |
| Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin D. | J Mol Biol | 2022 | 35341741 | PubTator, text mining | PubMed |
| Mitochondrial ATP synthase inhibitory factor 1 interacts with the p53-cyclophilin D complex and promotes opening of the permeability transition pore. | J Biol Chem | 2022 | 35337801 | PubTator, text mining | PubMed |
| Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases. | Biochem Pharmacol | 2022 | 35314166 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Cyclophilin D regulation of the mitochondrial permeability transition pore. | Curr Opin Physiol | 2022 | 35296110 | PubTator, text mining | PubMed |
| A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis. | Environ Toxicol | 2022 | 35234341 | PubTator, text mining | PubMed |
| Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders. | Int J Mol Sci | 2022 | 35162956 | PubTator, text mining | PubMed |
| Mutation Characteristics and Phylogenetic Analysis of Five Leishmania Clinical Isolates. | Animals (Basel) | 2022 | 35158645 | PubTator, text mining | PubMed |
| HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis. | Front Oncol | 2022 | 35127545 | PubTator, text mining | PubMed |
| Molecular mechanisms of amyloid disaggregation. | J Adv Res | 2022 | 35127169 | PubTator, text mining | PubMed |
| Perfluorooctanoic acid induces hepatocellular endoplasmic reticulum stress and mitochondrial-mediated apoptosis in vitro via endoplasmic reticulum-mitochondria communication. | Chem Biol Interact | 2022 | 35123991 | PubTator, text mining | PubMed |
| Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation. | Biochem Biophys Res Commun | 2022 | 35085894 | PubTator, text mining | PubMed |
| Targeting the mitochondrial permeability transition pore for drug discovery: Challenges and opportunities. | Mitochondrion | 2022 | 35077882 | PubTator, text mining | PubMed |
| Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma. | Aging (Albany NY) | 2022 | 35077391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5481/papers?page=12